Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-cell Lymphoma
…, I Chowdhury, O Dufva, E Sahlberg, L Tandaric… - Blood Cancer …, 2024 - AACR
Pathomechanisms that activate oncogenic B-cell receptor (BCR) signaling in diffuse large B-
cell lymphoma (DLBCL), are largely unknown. Kelch-like family member 6 (KLHL6) …
cell lymphoma (DLBCL), are largely unknown. Kelch-like family member 6 (KLHL6) …
1195 Results of NSGO-OV-UMB1/ENGOT-OV30 study: a phase II study of durvalumab and oleclumab in patients with relapsed ovarian cancer (OC)
…, RD Christensen, M Waldstroem, L Tandaric… - 2021 - ijgc.bmj.com
Introduction/Background* The primary objective of this multicentre, phase II study was to
evaluate the preliminary efficacy of O (3000mg, IV q2W) in combination with D (1500mg, IV …
evaluate the preliminary efficacy of O (3000mg, IV q2W) in combination with D (1500mg, IV …
Otaku subkultura u Hrvatskoj
L Tandarić - 2016 - darhiv.ffzg.unizg.hr
Otaku subculture is one of the most recent subcultures in Croatia. This subculture originated
in Japan in the early 1980s, while technological development enabled it to spread across …
in Japan in the early 1980s, while technological development enabled it to spread across …
2022-LBA-1231-ESGO Use of mass cytometry analysis of human peripheral blood mononuclear cells to identify cell subsets for monitoring combined immunotherapy …
L Tandaric, JR Henriksen, LCV Thomsen… - 2022 - ijgc.bmj.com
Introduction NSGO-OV-UMB1/ENGOT-OV-30–cohort A is a single-arm, open-label phase II
study of the combination of immune checkpoint inhibitors: durvalumab (anti-PD-L1) and …
study of the combination of immune checkpoint inhibitors: durvalumab (anti-PD-L1) and …
9 Advanced orthotopic ovarian cancer patient-derived xenograft models for improved preclinical evaluation of immunotherapies
K Kleinmanns, M Lode, SE Gullaksen, L Tandaric… - 2023 - jitc.bmj.com
Background Ovarian cancer (OC) is a heterogeneous disease, often diagnosed at an
advanced stage. After an initial encouraging response rate to first-line treatment, comprising …
advanced stage. After an initial encouraging response rate to first-line treatment, comprising …
[CITATION][C] YES.
…, A Painting, P Portraits, I Art, G Art, F Art, L Tandaric… - 2005 - pinterest.ca
[PDF][PDF] Sveti Ćiril i Metodije-novi pristup evangelizaciji
L Tandarić - Bogoslovska smotra, 1985 - hrcak.srce.hr
Ove ée se godine u vise navrata u naãoj zemlji iu drugim slavenskim zemljama slaviti
uspomena svete brace Cirila i Metodija zbog 1100. obljetnice smrti sv Metodija, s …
uspomena svete brace Cirila i Metodija zbog 1100. obljetnice smrti sv Metodija, s …
[PDF][PDF] Hrvatskoglagoljski» Misal po zakonu Rimskoga dvora «
L Tandarić - Crkva u svijetu: Crkva u svijetu, 1984 - hrcak.srce.hr
U ovom liturgijskom ozračju molitve i pjesme slavimo nesvakidašnji jubilej: petsto godina od
završetka tiskanja Misala po zakonu Rimskoga dvora, prve hrvatske tiskane knjige, a ujedno …
završetka tiskanja Misala po zakonu Rimskoga dvora, prve hrvatske tiskane knjige, a ujedno …
Die Marienverehrung in den kroatisch-glagolischen Liturgiekodices
JL Tandarić - Bogoslovska smotra, 1982 - hrcak.srce.hr
Sažetak Eine Erörterung der Marienverehrung in den kroatisch-glagolitischen
Liturgiekodices ist bedeutungsvoll, weil es sich dabei um eine Liturgie, die territorial auf den …
Liturgiekodices ist bedeutungsvoll, weil es sich dabei um eine Liturgie, die territorial auf den …
Istraživanje osjetljivosti stanične linije SU-DHL-5 s mutacijama gena KLHL6 na lijekove
L Tandarić - 2019 - repozitorij.pmf.unizg.hr
Sažetak Difuzni velikostanični B-limfom (DLBCL, od eng. diffuse large B-cell lymphoma)
najučestaliji je oblik ne-Hodgkinovog limfoma. Svjetska zdravstvena organizacija trenutno …
najučestaliji je oblik ne-Hodgkinovog limfoma. Svjetska zdravstvena organizacija trenutno …